Solid Dispersions for Drug Delivery Applications and Preparation Methods
Since their first application in the improvement of solubility of orally delivered drugs, applications of solid dispersions have considerably expanded to include cancer, infections, and inflammatory conditions. This book presents recent advancements in the development and use of solid dispersions fo...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_78726 | ||
| 005 | 20220224 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220224s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-2638-6 | ||
| 020 | |a 9783036526386 | ||
| 020 | |a 9783036526393 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-2638-6 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a KNDP |2 bicssc | |
| 100 | 1 | |a Khutoryanskiy, Vitaliy |4 edt | |
| 700 | 1 | |a Al-Obaidi, Hisham |4 edt | |
| 700 | 1 | |a Khutoryanskiy, Vitaliy |4 oth | |
| 700 | 1 | |a Al-Obaidi, Hisham |4 oth | |
| 245 | 1 | 0 | |a Solid Dispersions for Drug Delivery |b Applications and Preparation Methods |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (243 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Since their first application in the improvement of solubility of orally delivered drugs, applications of solid dispersions have considerably expanded to include cancer, infections, and inflammatory conditions. This book presents recent advancements in the development and use of solid dispersions for different therapeutic applications. This book can be particularly useful for researchers as well as postgraduate students in formulation sciences and drug delivery. Undergraduate students will also find elements of this book very relevant to scientific fundamentals such as solubility and crystallization of amorphous materials as well as drug delivery challenges. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Pharmaceutical industries |2 bicssc | |
| 653 | |a solid dispersions | ||
| 653 | |a drug delivery | ||
| 653 | |a biological applications | ||
| 653 | |a solid dispersion | ||
| 653 | |a delivery system | ||
| 653 | |a polymeric carriers | ||
| 653 | |a antichagasic activity | ||
| 653 | |a fexofenadine hydrochloride | ||
| 653 | |a PEG 20,000 | ||
| 653 | |a poloxamer188 | ||
| 653 | |a dissolution | ||
| 653 | |a absorption | ||
| 653 | |a green nanotechnology | ||
| 653 | |a raloxifene | ||
| 653 | |a nanoemulsion | ||
| 653 | |a core-sheath nanofibers | ||
| 653 | |a response surface methodology | ||
| 653 | |a ex vivo drug permeation | ||
| 653 | |a in vivo pharmacokinetic studies | ||
| 653 | |a acalabrutinib | ||
| 653 | |a amorphous solid dispersion | ||
| 653 | |a acid-reducing agent | ||
| 653 | |a bioavailability enhancement | ||
| 653 | |a kinase inhibitor | ||
| 653 | |a pH effect | ||
| 653 | |a proton pump inhibitor | ||
| 653 | |a spray drying | ||
| 653 | |a hydrogen bonding | ||
| 653 | |a hydrophobicity | ||
| 653 | |a poly(N-vinyl pyrrolidone) | ||
| 653 | |a poly(2-oxazolines) | ||
| 653 | |a crystallinity | ||
| 653 | |a hydrophobic drug | ||
| 653 | |a amorphous | ||
| 653 | |a ibuprofen | ||
| 653 | |a drug-rich phase | ||
| 653 | |a liquid-liquid phase separation | ||
| 653 | |a permeability enhancement | ||
| 653 | |a cocrystals | ||
| 653 | |a coamorphous | ||
| 653 | |a solubility | ||
| 653 | |a dry powder inhalers | ||
| 653 | |a pulmonary drug delivery | ||
| 653 | |a acid reducing agent | ||
| 653 | |a in silico prediction | ||
| 653 | |a absorption modeling | ||
| 653 | |a GastroPlus | ||
| 653 | |a paroxetine | ||
| 653 | |a nanosuspension | ||
| 653 | |a oral fast dissolving film | ||
| 653 | |a factorial design | ||
| 653 | |a rapid release | ||
| 653 | |a ex vivo permeation | ||
| 653 | |a bioavailability | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4817 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/78726 |7 0 |z DOAB: description of the publication |